| pubmed-article:21276607 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21276607 | lifeskim:mentions | umls-concept:C0677886 | lld:lifeskim |
| pubmed-article:21276607 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:21276607 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:21276607 | lifeskim:mentions | umls-concept:C1515673 | lld:lifeskim |
| pubmed-article:21276607 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:21276607 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21276607 | pubmed:dateCreated | 2011-3-22 | lld:pubmed |
| pubmed-article:21276607 | pubmed:abstractText | Activation of the mammalian target of rapamycin (mTOR) pathway enhances cell survival and growth by regulating the efficiency of protein translation. This study was conducted to evaluate the association of activated mTOR signaling molecules with the clinicopathologic characteristics in epithelial ovarian cancer. | lld:pubmed |
| pubmed-article:21276607 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21276607 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21276607 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21276607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21276607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21276607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21276607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21276607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21276607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21276607 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21276607 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21276607 | pubmed:issn | 1095-6859 | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:KimJae WeonJW | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:LimJeong... | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:KimYong-BeomY... | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:HanJae YongJY | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:ParkIn-AeIA | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:SongYong-Sang... | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:KangSoon-Beom... | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:JeonYong-Tark... | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:ParkNoh-HyunN... | lld:pubmed |
| pubmed-article:21276607 | pubmed:author | pubmed-author:NoJae HongJH | lld:pubmed |
| pubmed-article:21276607 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:21276607 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21276607 | pubmed:volume | 121 | lld:pubmed |
| pubmed-article:21276607 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21276607 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21276607 | pubmed:pagination | 8-12 | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:meshHeading | pubmed-meshheading:21276607... | lld:pubmed |
| pubmed-article:21276607 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21276607 | pubmed:articleTitle | Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer. | lld:pubmed |
| pubmed-article:21276607 | pubmed:affiliation | Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea. | lld:pubmed |
| pubmed-article:21276607 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21276607 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| entrez-gene:2475 | entrezgene:pubmed | pubmed-article:21276607 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:21276607 | lld:entrezgene |
